Universal Digital Announces the Filing of Amended and Restated Financial Statements and MD&A’s 
Victory Square Technologies Reports Q2 2025 Results Highlighted by Revenue Growth, Profitability, and Portfolio Momentum 
American Aires Inc. Announces Business Continuity and Governance Actions Following Special Committee Review 
Zeebu Reaches $10 Billion Settlement Milestone, Proves Programmable Payments Are Production-Ready Bavarian Nordic Announces Marketing and Distribution Agreement with Dynavax to Launch HEPLISAV B® Hepatitis B Vaccine in Germany
COPENHAGEN, Denmark, May 27 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) has entered…
Novartis and Molecular Partners announce start of EMPATHY clinical trial for ensovibep for the treatment of COVID-19
EMPATHY global multi-center Phase 2 – 3 study, recruiting patients with COVID-19 infection, aiming to…
Santhera Publishes Agenda for its Annual General Meeting
Pratteln, Switzerland, May 27, 2021 – Santhera Pharmaceuticals (SIX: SANN) announces the invitation to its Annual…
Day One Announces Pricing of Upsized Initial Public Offering
SOUTH SAN FRANCISCO, Calif., May 26, 2021 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals, Inc. (Nasdaq:…
Reviva Announces Pricing of Upsized $30 Million Underwritten Public Offering
CUPERTINO, Calif., May 26, 2021 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva”…
Ocugen On Track to Submit Emergency Use Authorization Application to U.S. FDA for its COVID-19 Vaccine Candidate, COVAXIN™
Active discussions with FDA related to COVAXIN initiated late last year Master file submitted to…
Scopus BioPharma to Reschedule 2021 Annual Meeting of Shareholders
NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) — Scopus BioPharma Inc. (Nasdaq: “SCPS”) today announced…
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives Emergency Use Authorization from the US FDA for Treatment of Mild-to-Moderate COVID-19 in High-Risk Adults and Pediatric Patients
– Treatment with sotrovimab resulted in an 85% reduction in the risk of hospitalization or…
MediPharm Labs Launches High-CBD Wellness Oils in Quebec; Ships First Order of CBD 25 and CBD 50 Formulas Now Available for Retail Sale by SQDC
BARRIE, Ontario, May 26, 2021 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF)…
ORIC Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, May 26, 2021 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals,…
ERYTECH to Participate in Upcoming Virtual Investor Conferences in June
ERYTECH to Participate in Upcoming Virtual Investor Conferences in June Lyon (France) and Cambridge, MA…
Intercept Announces Updated Ocaliva® (obeticholic acid) U.S. Prescribing Information
New contraindication applies to a subset of patients with primary biliary cholangitis (PBC) with decompensated…
Paratek Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference
BOSTON, May 26, 2021 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical…
Lexicon Pharmaceuticals to Participate in the 2021 Jefferies Virtual Healthcare Conference
THE WOODLANDS, Texas, May 26, 2021 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today…
Myovant Sciences and Pfizer Receive FDA Approval for MYFEMBREE®, the First Once-Daily Treatment for Heavy Menstrual Bleeding Associated With Uterine Fibroids
In the Phase 3 LIBERTY 1 and LIBERTY 2 studies, MYFEMBREE demonstrated 72.1% and 71.2%…
BeyondSpring to Present at the Jefferies Virtual Healthcare Conference on June 3, 2021
NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) — BeyondSpring Inc. (“BeyondSpring”) (NASDAQ: BYSI), a global…
Zealand Pharma to participate in Jefferies Virtual Healthcare Conference
Company announcement – No. 32/ 2021 Zealand Pharma to participate in Jefferies Virtual Healthcare Conference Copenhagen,…
Zosano Pharma Announces Publication of Clinical Data Regarding the Long-term use of Qtrypta™ for the Treatment of Acute Migraine in The Journal of Headache and Pain
FREMONT, Calif., May 26, 2021 (GLOBE NEWSWIRE) — Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company,…
Timber Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2b CONTROL Study Evaluating TMB-001 in Congenital Ichthyosis
– Company plans to ask for end-of-Phase 2 meeting with FDA by end of 2021…
Celldex to Present at the Jefferies 2021 Virtual Healthcare Conference
HAMPTON, N.J., May 26, 2021 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that…